Navigation Links
Quest Diagnostics to Release Fourth Quarter and Full Year 2008 Financial Results
Date:1/12/2009

MADISON, N.J., Jan. 12 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it will report fourth-quarter and full year 2008 results and provide financial guidance for 2009 on Monday, January 26, before the market opens. It will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. ET on that day.

The public may access the conference call through a live audio webcast available on Quest Diagnostics' Investor Relations link on the Internet at www.QuestDiagnostics.com/investor.

The conference call can also be accessed by dialing 415-228-4961, passcode 3214469.

The company suggests participants dial in approximately 10 minutes before the call. Please note that this feature will be in listen-only mode.

A replay of the call may be accessed through the Internet at www.QuestDiagnostics.com/investor or by dialing 866-431-7950, or 203-369-0981 for international callers. No access code will be required. Telephone replays will be available from 10:30 a.m. ET on January 26 until midnight ET on February 23, 2009.

Anyone listening to the Quest Diagnostics call is encouraged to read Quest Diagnostics' periodic reports on file with the Securities and Exchange Commission, including the discussion of risk factors and historical results of operations and financial condition in those reports.

Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest acces
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Effectiveness of mouse breeds that mimic Alzheimers disease symptoms questioned
2. The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise
3. LifeQuest Announces End of Immunity Health Challenge Contest
4. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
5. Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference
6. Study Questions Dead-End Cancer Clinical Trials
7. 6 Years Later, 9/11 Health Questions Linger
8. U.S. Physicians Question Presidential Candidates
9. RFID Implant Cancer Questions Concern Patients
10. Study Questions Genetic Screening for Treatable Diseases
11. Mass. Judge Denies Request by Breastfeeding Mother for More Break Time on Medical Licensing Exam
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... the heterogeneity the variety of genetic mutations of ... patients with the most common type of head and neck ... Cancer , investigators at Massachusetts General Hospital (MGH) and ... a better predictor of survival than most traditional risk factors ... of the head and neck. , "Our findings ...
(Date:5/19/2013)... May 19, 2013 Alonso Krangle LLP ... diving accident lawsuit on behalf of a-24-year-old financial ... into shallow water. The diving accident lawsuit, which was filed ... County, alleges the Defendant held the property out as a ... diving in the area. (Case No. 34556/12) , According to ...
(Date:5/19/2013)... (PRWEB) May 20, 2013 The three ... Summit Medical Group: David A. Abrutyn, M.D., Robert S. ... to see patients at their current location, 215 Union ... M.D., has expertise in sports medicine, with emphasis on ... pediatric, adolescent, and adult patients for a wide range ...
(Date:5/19/2013)... 2013 At a May 6th, ... Asian Pacific Physicians (NCAPIP), the Pacific Chronic Disease ... of Chronic Disease Directors (NACDD), presented a newly ... diabetes, and non-communicable diseases (NCDs) in the U.S. ... in the Hawaii Journal of Medicine and Public ...
(Date:5/19/2013)... HealthDay Reporter , , SATURDAY, May 18 ... those with Crohn,s disease overcome the fatigue and ... disease, according to new research. Extra vitamin ... and general fatigue, greater quality of life and ... said Tara Raftery, a research dietitian and doctoral ...
Breaking Medicine News(10 mins):Health News:Genetic diversity within tumors predicts outcome in head and neck cancer 2Health News:Genetic diversity within tumors predicts outcome in head and neck cancer 3Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 2Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 3Health News:Summit Medical Group Welcomes the Center for Orthopedic Care 2Health News:Summit Medical Group Welcomes the Center for Orthopedic Care 3Health News:Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions 2Health News:Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions 3Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 2Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 3
... the combination of just two genes, according to a new study ... of Clinical Endocrinology and Metabolism this week, identifies one gene on ... height in men. These genes may also help explain why men ... of both of these genes you will be taller than a ...
... that, too much sleep and snoring could put you at ... of Buffalo, New York, have found that sleeping more than ... day can damage your health. Experts say this means snoring ... seriously.// ,Dr David Smithard, Consultant in Stroke Medicine ...
... Doctors from England are trialling the first long-acting male contraceptive ... every three months, is a combination of hormones. ,In ... then a pellet of the male hormone testosterone is placed ... from the Royal Kings Hospital in UK says the technique ...
... exercise is a better indicator of heart disease risk than ... risk of heart disease and stroke. Normally, doctors measure blood ... But researchers at University of San Diego now show that ... be treated and detected.// ,They measured the blood pressure ...
... new test really helps detect heart problems. A test for cardiac ... are really having a heart attack. Only 10 to 15 per ... chest pain are actually having a heart attack. Other causes of ... test may take several hours and maybe a formal hospital admission ...
... found that genes contribute to the risk of chronic ... (COPD), the name given to chronic bronchitis and emphysema ... shortness of breath. It's linked with gradual destruction of ... the problem.// ,However, not all smokers go ...
Cached Medicine News:
(Date:5/17/2013)... -- Sanofi (EURONEXT: SAN and NYSE: SNY ) announced ... , examining the selective JAK2 inhibitor SAR302503 for myelofibrosis ... The primary endpoint assessed the proportion of patients achieving ... in previous trials, the most common adverse events were ... presented at an upcoming medical congress. ...
(Date:5/16/2013)... , May 17, 2013 ... and Switzerland,s Cytos Biotechnology AG today ... a Phase 1 clinical trial with their H1N1 influenza vaccine ... technology. In this first Phase 1 clinical trial, the safety ... to protect against H1N1 influenza infection will be evaluated. ...
(Date:5/16/2013)... N.C. , May 16, 2013  Today, the ... North Carolina House of Representatives recently approved ... for chemotherapy from charging patients higher out-of-pocket fees for ... formularies, many of which have more severe side-effects. However, ... limit of $300, which will continue to be a ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... obesity and,complications arising from popular aesthetic surgical procedure, ... study,investigating the relationship between complications of body contouring,surgery ... in the occurrence of,such complications with worsening degree ... the July/August 2008 issue of the Aesthetic Surgery,Journal, ...
... MOORESVILLE, N.C., July 30 Anpath Group, Inc.,(OTC ... owned,subsidiary, EnviroSystems, Inc. (ESI) announced that its EnviroTru(R),disinfectant ... Department of,Management Services (DMS) in the State of ... of Green, LLC(TM) ( http://www.aworldofgreen.com ),worked ...
Cached Medicine Technology:Body Contouring Surgery Risk Rises with Increased Body Mass Index 2Body Contouring Surgery Risk Rises with Increased Body Mass Index 3Anpath Group, Inc. Announces Approval of its Disinfectant by the State of Florida 2Anpath Group, Inc. Announces Approval of its Disinfectant by the State of Florida 3
The Unistik 3 family of single use safety lancets has 4 models for use across all clinical environments....
... complete range of needle sizes to ensure that ... be obtained with any skin type, quickly, easily ... of needle diameters enable users to obtain blood ... damage. This makes it easier to comply with ...
Lancets are the fine needles used with a lancing device to draw a blood sample for glucose testing. To make testing less painful, we developed lancets with extra-thin tips....
Lancets are the fine needles used with a lancing device to draw a blood sample for glucose testing. To make testing less painful, we developed lancets with extra-thin tips....
Medicine Products: